Diality Treats First Patient with Moda-flx Hemodialysis System
Diality, a cutting-edge medical device company specializing in smart, flexible hemodialysis platforms, has announced the successful completion of the first-ever patient treatment with its Moda-flx Hemodialysis System™. This milestone was achieved in collaboration with the North America Research Institute at Ontario-Holt Dialysis Center in Ontario, California.
“We are incredibly proud to achieve this significant milestone and are excited about the potential this technology holds for improving the lives of patients facing kidney disease,” said Osman Khawar, M.D., CEO of Diality. “Our partnership with the North America Research Institute marks an important step forward in our mission to offer innovative, life-changing solutions for those affected by kidney disease. This is just the beginning, as we plan to treat many more patients, all of whom will benefit from a more tailored and comfortable dialysis experience with the Moda-flx Hemodialysis System.”
Revolutionizing Kidney Care with Flexibility and Control
The Moda-flx Hemodialysis System is a state-of-the-art platform designed to give kidney care professionals greater flexibility in tailoring dialysis treatments to meet the specific needs of individual patients. Featuring a wide range of adjustable flow rates, integrated reverse osmosis water filtration, and a user-friendly graphical interface, the system offers clinicians the ability to personalize each treatment session. The compact and mobile design of the system also facilitates easy integration and transportation within dialysis settings, ensuring seamless usage in both acute and chronic care environments.
Dr. Aamir Jamal, CEO of North America Research Institute, praised the system’s ability to personalize treatments: “New kidney care technologies like the Moda-flx Hemodialysis System are exactly what the industry needs. The clinical flexibility it provides allows us to adapt dialysis prescriptions to better meet the needs of our patients, providing a level of precision and control that traditional systems do not offer. We now have the ability to choose the most appropriate dialysis regimen for each patient with confidence, knowing that the system will deliver the therapy needed for their well-being.”
Customized Treatment for Acute and Chronic Renal Failure
The Moda-flx Hemodialysis System is indicated for patients suffering from acute or chronic renal failure, with or without ultrafiltration, in both acute and post-acute care settings as well as chronic care facilities. Treatments are to be administered under a physician’s prescription by a trained professional. The system offers a variety of treatment types, including Intermittent Hemodialysis (IHD), Sustained Low Efficiency Dialysis (SLED/SLEDD), and Prolonged Intermittent Renal Replacement Therapy (PIRRT).
This flexibility allows the Moda-flx Hemodialysis System to address the diverse needs of patients, empowering clinicians to choose the most appropriate method based on patient condition and treatment goals. The ability to customize dialysis prescriptions directly benefits patients by enhancing treatment efficacy, improving patient comfort, and optimizing overall outcomes.
A Bright Future for Diality’s Groundbreaking Platform
Diality’s mission is to provide effective, patient-centered solutions to improve kidney care, and the company’s groundbreaking Moda-flx Hemodialysis System is a testament to that commitment. The system was granted U.S. FDA clearance in August 2024, and the first successful patient treatment marks an important step in making this innovative technology more widely available.
“We are on the precipice of something truly transformative,” said Khawar. “The Moda-flx Hemodialysis System has the potential to redefine how dialysis is delivered, offering a level of flexibility and ease-of-use that can lead to better clinical outcomes and improved quality of life for patients. This is a big win for the future of kidney care, and we are excited to continue pushing the boundaries of innovation in this space.”
About Diality
Diality is a forward-thinking medical device company focused on advancing hemodialysis treatment to improve the lives of patients with kidney disease. Its flagship product, the Moda-flx Hemodialysis System, combines the functionality of in-center systems with the convenience and mobility of next-generation dialysis devices. The system is designed for clinical flexibility, enabling healthcare providers to customize treatment and enhance patient outcomes. Diality aims to revolutionize kidney care with solutions that prioritize patient comfort and clinical efficacy.
About North America Research Institute
The North America Research Institute is dedicated to providing innovative kidney care through clinical trials, with a broad network of dialysis and medical centers across Southern California. The institute’s focus is on delivering high-quality, compassionate care to help patients manage their kidney conditions and live healthier lives.
Please find the related post
